APOGEPHA

APOGEPHA Arznei­mittel GmbH is a modern, independent, medium-sized family business founded in 1882 in Dresden, Germany. It is highly focused on the field of urology. The company's main product, Propiverine (trademarks: Mictonorm®, Mictonorm Uno®, Mictonetten®, Detrunorm®, Detrunorm® XL, and BUP-4®), is used to treat urinary incontinence and overactive bladder in adults and children.